Banque Transatlantique SA cut its stake in Danaher Corporation (NYSE:DHR – Free Report) by 23.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 173,803 shares of the conglomerate’s stock after selling 53,861 shares during the period. Danaher accounts for 1.0% of Banque Transatlantique SA’s investment portfolio, making the stock its 21st largest holding. Banque Transatlantique SA’s holdings in Danaher were worth $39,868,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Enterprise Financial Services Corp boosted its stake in shares of Danaher by 1.4% in the 4th quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock valued at $737,000 after purchasing an additional 46 shares during the last quarter. Kennebec Savings Bank raised its stake in Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after buying an additional 46 shares during the last quarter. Revolve Wealth Partners LLC lifted its holdings in Danaher by 2.6% in the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock valued at $428,000 after buying an additional 47 shares during the period. High Note Wealth LLC boosted its position in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 47 shares during the last quarter. Finally, First Command Advisory Services Inc. boosted its position in Danaher by 4.4% during the fourth quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.
Danaher Trading Down 0.0%
NYSE DHR opened at $177.74 on Friday. The company has a market cap of $125.80 billion, a price-to-earnings ratio of 34.38, a P/E/G ratio of 2.27 and a beta of 0.81. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The business has a 50 day moving average price of $179.99 and a 200-day moving average price of $203.25. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.
Danaher Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.
Wall Street Analysts Forecast Growth
DHR has been the topic of a number of recent analyst reports. Robert W. Baird dropped their price objective on Danaher from $251.00 to $249.00 and set an “outperform” rating on the stock in a research note on Friday, April 17th. JPMorgan Chase & Co. cut their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, DZ Bank assumed coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $233.61.
View Our Latest Research Report on DHR
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
